Elisa García-Garré

Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer

Elena García-Martínez, Ginés Luengo‐Gil, Asunción Chaves Benito et al. · Breast Cancer Research · 2014 · 254 citations · Full text

Medicine, Immunology, Oncology +16

Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients

Isabel Chirivella, Begoña Bermejo, Amelia Insa et al. · Breast Cancer Research and Treatment · 2008 · 174 citations · Full text

Medicine, Oncology, Pharmacology +16

Angiogenic role of miR-20a in breast cancer

Ginés Luengo‐Gil, Enrique González‐Billalabeitia, Sergio Alejo Perez-Henarejos et al. · PLoS ONE · 2018 · 72 citations · Full text

Medicine, Cancer Biology, Oncology +17

Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens

José Alejandro Pérez Fidalgo, Susana Roselló, Elisa García-Garré et al. · Breast Cancer Research and Treatment · 2009 · 65 citations · Full text

Medicine, Oncology, Pharmacology +14

Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy

Ginés Luengo‐Gil, Elena García-Martínez, Asunción Cháves-Benito et al. · Cellular Oncology · 2019 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +17